Sodium-Glucose Cotransporter-2 Inhibitors in Transthyretin Amyloid Cardiomyopathy

被引：0

作者：

Porcari, Aldostefano ^{[1
]}

Cappelli, Francesco ^{[2
]}

Nitsche, Christian ^{[3
]}

Tomasoni, Daniela ^{[4
]}

Sinigiani, Giulio ^{[5
]}

Longhi, Simone ^{[6
]}

Bordignon, Luca ^{[7
]}

Masri, Ahmad ^{[8
]}

Serenelli, Matteo ^{[9
]}

Urey, Marcus A. ^{[10
]}

Musumeci, Beatrice ^{[11
]}

Cipriani, Alberto ^{[12
]}

Canepa, Marco ^{[13
]}

Eslam, Roza Badr ^{[14
]}

Kronberger, Christina ^{[3
]}

Chimenti, Cristina ^{[15
]}

Zampieri, Mattia ^{[2
]}

Allegro, Valentina ^{[7
]}

Razvi, Yousuf ^{[16
]}

Patel, Rishi ^{[17
]}

Ioannou, Adam ^{[17
]}

Rauf, Muhammad U. ^{[17
]}

Petrie, Aviva ^{[18
]}

Whelan, Carol ^{[19
,20
]}

Emdin, Michele ^{[21
]}

Metra, Marco ^{[22
]}

Merlo, Marco ^{[7
]}

Sinagra, Gianfranco ^{[7
]}

Hawkins, Philip ^{[17
]}

Solomon, Scott ^{[23
]}

Gillmore, Julian ^{[17
]}

Fontana, Marianna ^{[17
]}

机构：

[1] UCL, Royal Free Hosp NHS Fdn Trust, Natl Amyloidosis Ctr, Div Med, London, England

[2] Univ Florence, Careggi Univ Hosp, Cardiomyopathy Unit, Florence, Italy

[3] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Vienna, Austria

[4] Univ Brescia, Dept Med & Surg Special Radiol Sci & Publ Hlth, Cardiol, ASST Spedali Civili, London, England

[5] Univ Padua, Dept Cardiac Thorac & Vasc Sci & Publ Hlth, Padua, Italy

[6] IRCCS Azienda Osped Univ Bologna, Cardiol Unit, Bologna, Italy

[7] Univ Trieste, Azienda Sanit Univ Giuliano Isontina, Cardiovasc Dept, Ctr Diag & Treatment Cardiomyopathies, Trieste, Italy

[8] OHSU, Knight Cardiovasc Inst, Portland, OR USA

[9] Ferrara Univ Hosp, Cardiol Ctr, Porto Recanati, Italy

[10] Univ Calif San Diego, Med Ctr, Dept Med, La Jolla, CA USA

[11] Sapienza Univ, Fac Med & Psychol, Dept Clin & Mol Med, Rome, Italy

[12] Univ Padua, Dept Cardiac Thorac & Vasc Sci & Publ Hlth, Padua, Italy

[13] Univ Genoa, Cardiovasc Unit, Genoa, Italy

[14] Med Univ Vienna, Div Cardiol, Vienna, Austria

[15] Sapienza Univ Rome, Policlin Umberto 1, Dept Cardiovasc Resp Dis Nephrol Anesthesiol & Ge, Rome, Italy

[16] Royal Free Hosp, London, England

[17] Royal Free Hosp, Natl Amyloidosis Ctr, London, England

[18] UCL, London, England

[19] Natl Amyloidosis Ctr, London, England

[20] UCL, Royal Free Hosp, Div Med, London, England

[21] Fdn Gabriele Monasterio, Cardiol Div, Pisa, Italy

[22] Univ Brescia, Cardiol Div, Brescia, Italy

[23] Brigham & Womens Hosp, Cardiovasc Dept, 75 Francis St, Boston, MA 02115 USA

来源：

CIRCULATION | 2023年 / 148卷 / 25期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

23010

引用

页码：E303 / E303

页数：1

共 50 条

[21] Sodium-glucose cotransporter-2 inhibitors in patients without diabetes
Fryml, Elise
Lanktree, Matthew B.
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (17) : E619 - E619
[22] Sodium-glucose cotransporter-2 inhibitors reduce the risk of gout
Pavlicek, Vojtech
DIABETOLOGE, 2020, 16 (02): : 190 - 191
[23] The impact of sodium-glucose cotransporter-2 inhibitors on cardiac function
Chen, I-Wen
Weng, Hsiu-Lan
Hung, Kuo-Chuan
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 130 - 131
[24] The pleiotropic cardiovascular effects of sodium-glucose cotransporter-2 inhibitors
Tanna, Monique S.
Goldberg, Lee R.
CURRENT OPINION IN CARDIOLOGY, 2021, 36 (06) : 764 - 768
[25] Sodium-glucose cotransporter-2 inhibitors: an overview and perioperative implications
Bardia, Amit
Wai, Mabel
Fontes, Manuel L.
CURRENT OPINION IN ANESTHESIOLOGY, 2019, 32 (01) : 80 - 85
[26] The Association Between Sodium-glucose Cotransporter-2 Inhibitors and Major Adverse Cardiac Events in Tafamidis-treated Transthyretin Amyloid Cardiomyopathy: A Real-World Analysis
Chi, Kuan Yu
Borkowski, Pawel
Osabutey, Anita
Varrias, Dimitrios
Song, Junmin
Chiang, Cho Han
Chang, Yu-Cheng
Lee, Pei Lun
Chang, Yu
Madan, Shivank
Patel, Snehal
CIRCULATION, 2024, 150
[27] Potential Utility of Sodium-Glucose Cotransporter-2 Inhibitors in Treating Myocarditis
Kim, Michael H.
Suri, Yash
Rajendran, Iniya
Pineda, J. R. Exequiel T.
AMERICAN JOURNAL OF MEDICINE, 2024, 137 (02): : e33 - e34
[28] Sodium-glucose cotransporter-2 inhibitors in cardiovascular disease: a gaseous solution
Durante, William
MEDICAL GAS RESEARCH, 2025, 15 (02): : 206 - 207
[29] Mortality Outcomes With Different Sodium-glucose Cotransporter-2 Inhibitors: Are They Dissimilar?
Singh, Awadhesh Kumar
ENDOCRINE PRACTICE, 2022, 28 (10) : 1107 - 1108
[30] Antifibrotic effects of sodium-glucose cotransporter-2 inhibitors: A comprehensive review
Shakour, Neda
Karami, Shima
Iranshahi, Mehrdad
Butler, Alexandra E.
Sahebkar, Amirhossein
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (01)

← 1 2 3 4 5 →